Low-intensity shockwave therapy improves erectile function in trials, but guidelines continue to classify it as ...

It’s more common than many people think,” says Arvind Kanda, Head of India & Access Markets at Viatris, as the global healthcare company pushes to break the silence around erectile dysfunction (ED) in ...

GLP-1 weight loss drugs may increase erectile dysfunction risk in men with Type 2 diabetes, but experts say evidence is ...

Weight Loss And Metabolic Shifts: Rapid weight loss and metabolic changes may alter hormone levels, which can influence ...

Accra, April 19, GNA – Viatris, a global healthcare company, has taken its EmpowerED for Life campaign to the streets of Accra to promote open discussion on erectile dysfunction (ED). The exercise, ...

A 2026 observational study suggests GLP-1 receptor agonists may be associated with a modest increase in erectile dysfunction ...

Find out more about the association between GLP-1 use in patients with Type 2 diabetes and erectile dysfunction.

Many men with ED - erectile dysfunction - think it's an isolated problem, and don't tell their doctors. However, they should ...

Initiator Pharma A/S, a clinical-stage biotech company, today announced that the company has decided to focus fully on its most promising drug candidate, pudafensine, which is being developed for both ...

Millions rely on Medicare Part D, but many prescription drugs won't be covered in 2026. See which meds are excluded, why, and ...

Type-2 diabetes has previously been linked with erectile dysfunction in men. However, the impact of GLP-1s has been recently ...